Cedric O'Gorman - Chief Medical Officer at Relmada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cedric O'Gorman since 10/4/2023

Holdings reported by Cedric O'Gorman for Relmada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10.1K $32.2K $3.18 May 23, 2023 Direct
Stock Option (right to buy) 400K Jan 6, 2023 Direct Common stock

Transactions reported by Cedric O'Gorman for Relmada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.